Searched for
HIV DRUG
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- True North buys 25% stake in pharma co EmbioPrivate equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients fo...
- Quote of the day by George Michael: 'Change is a stranger you have yet to know.' Life lessons on human nature, success and hardships by British singer and songwriterQuote of the day by George Michael explores the meaning of change through the words “Change is a stranger you have yet to know.” The articl...
- New Zealand eases health insurance rules for Peak Seasonal Visa from April 19New Zealand is easing health insurance rules for the Peak Seasonal Visa starting April 19, 2026. This change aims to simplify compliance fo...
- Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its boardAnthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI syst...
- 'Chitta took all my sons': Punjab woman loses all five children to drugs, breaks down in painA mother in Punjab's Kapurthala tragically lost all her sons to chitta, also known as drugs. The critically ill patient died at Amritsar Me...
- Generic HIV drug rollout to take a hit on trial pushIndia's decision to reject a waiver for local clinical trials of a new HIV drug, lenacapavir, is causing concern. Public health experts war...
- Lupin gets USFDA nod for generic HIV drugLupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at Lupin's Nagpur ...
- Quick access to key HIV drug hinges on waiver of local clinical trials: ExpertsFaster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three from India, ha...
- Dr Reddy's enters voluntary licensing deal with Gilead for long-acting HIV drugDr. Reddy’s has partnered with Gilead Sciences to manufacture and market the HIV drug Lenacapavir in India and 120 other countries. The agr...
- Activists sound alarm bells as Gilead seeks rights over HIV drugLenacapavir, a very expensive drug, is not available in India and many other countries. If the Indian Patent Office clears Gilead's patent ...
- New 'vaccine-like' HIV drug could cost just $40: ResearchersA new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated...
- Combination of two anti-HIV drugs proved crucial in Coronavirus treatment, Rajasthan officialAdditional Chief Secretary (Medical and Health) Rohit Kumar Singh said the patients' condition improved after they were administered the an...
- Payment delays by NACO causing HIV drugs scarcityCipla, the sole producer of lopinavir/ritonavir, a combination HIV drug prescribed for paediatric patients, has stopped manufacturing it ov...
- Two-drug combo pill to treat HIVScientists have developed a new delivery system for a combination of two HIV drugs that may serve as an effective treatment for the deadly ...
- Big pharma companies must allow generic firms to sell cheap HIV drugs to poor nationsAn independent mechanism that protects the patent rights of Big Pharma while allowing generic firms to sell cheap, copycat HIV drugs to poo...
- Bristol-Myers patent plea for HIV drug rejectedIndia has rejected American drugmaker Bristol-Myers Squibb's (BMS) patent application for one of its HIV drugs, allowing local drugmakers t...
- Abbott patent application for HIV drug spurnedBesides I-MAK, a few local HIV drug makers such as Cipla and US-based Mylan-owned Matrix Laboratories had also opposed Abbott's attempt to ...
- PSU pharmas likely to make HIV drugsIn a bid to make anti-cancer and HIV drugs more accessible, the government is planning to ask public sector drug makers to manufacture anti...
Load More
